PRVA Privia Health Group, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Privia Health Group, Inc. (PRVA) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 27, 2026, a 10-Q quarterly report filed on May 7, 2026, an 8-K current report filed on August 6, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Privia Health Group, Inc. (PRVA) (SEC CIK 1759655), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business: technology-driven physician enablement platform combining regional medical group partnership with provider autonomy, focused on value-based care (VBC) and provider workflow optimization
- • New emphasis: expansion of Privia Women’s Health and Pediatrics platforms and growth in virtual health services (4.7M virtual visits by 1.5M patients in 2025)
- • Strategic shift: accelerated transition of markets from fee-for-service (FFS) to value-based care, increasing attributed risk lives and emphasizing direct contracting with payers and employers
- • Quantitative highlights: 5,380 Privia Providers across 1,300+ locations serving 5.8M patients; 10 ACOs serving 298,000 Medicare beneficiaries in 2025, with $233.1M shared savings in 2024 (32% YoY increase)
- • Noteworthy: Privia achieved per capita cost savings 8%-35% below median MSSP and FFS Medicare benchmarks, reflecting strong cost control in government programs
Risk Factors
- • Cybersecurity incident risk with potential to compromise patient and business data, cause operational disruption, and trigger costly remediation and liability
- • Board-level oversight of cybersecurity risks involving CISO with 15+ years health IT leadership, ensuring monthly updates to executive leadership
- • Operational risk from reliance on third-party vendors and complex multi-tiered access controls managed by a dedicated Third Party Access Committee
- • Potential reputational and legal harm from failure to manage evolving cybersecurity threat landscape through active Cybersecurity Incident Response Team
- • No disclosed financial leverage, market disruption, geopolitical, or specific regulatory risks in this section
Management Discussion & Analysis
- • Operating lease expense $3.2M in 2025 vs $2.8M in 2024 and $2.7M in 2023
- • Administrative service rebates $3.5M in 2025, $1.8M in 2024, $2.7M in 2023
- • No off-balance sheet obligations as of December 31, 2025
- • Revenue recognition based on FFS-patient care, administrative services, and VBC contracts including capitation, shared savings, and PMPM models
- • No specific YoY revenue or margin % changes disclosed; forward guidance or emerging risks not provided in this section
Go deeper on Privia Health Group, Inc.
Ask AI about PRVA filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting PRVA positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on PRVA.
Annual Reports Archive10-K
AI-powered analysis of Privia Health Group, Inc. (PRVA) 10-K annual reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Privia Health Group, Inc. (PRVA) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Profitability | |||
| Revenue | $1.7B | $1.7B | $2.1B |
| Operating Income | $20.6M | $17.0M | $34.2M |
| Net Income | $23.1M | $14.4M | $22.9M |
| Op. Margin | 1.2% | 1.0% | 1.6% |
| Net Margin | 1.4% | 0.8% | 1.1% |
| Balance Sheet | |||
| Total Assets | - | $1.1B | $1.4B |
| Equity | $561.4M | $635.2M | $737.2M |
| ROE | 4.1% | 2.3% | 3.1% |
| Per Share | |||
| EPS | $0.19 | $0.11 | $0.18 |
| Cash Flow | |||
| Operating CF | - | $109.3M | $163.4M |
| CapEx | $113K | - | - |
Source: XBRL financial data from Privia Health Group, Inc. (PRVA) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Aug 6, 2026 | - | - | - |
8-K | Jul 7, 2026 | - | - | - |
8-K | May 22, 2026 | - | - | |
8-K | May 7, 2026 | - | - | |
10-Q | May 7, 2026 | Mar 31, 2026 | - | |
10-K | Feb 27, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 26, 2026 | - | Analysis | - |
8-K | Dec 8, 2025 | - | - | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | - | |
10-Q | May 8, 2025 | Mar 31, 2025 | - | |
10-K | Feb 27, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | - | |
10-Q | May 9, 2024 | Mar 31, 2024 | - | |
10-K | Feb 27, 2024 | Dec 31, 2023 | - | |
SC 13G | Feb 13, 2024 | - | - | |
10-Q | Nov 3, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 3, 2023 | Jun 30, 2023 | - | |
SC 13G | Jul 7, 2023 | - | - | |
SC 13G | Jun 12, 2023 | - | - | |
SC 13G | May 15, 2023 | - | - | |
10-Q | May 4, 2023 | Mar 31, 2023 | - | |
10-K | Mar 1, 2023 | Dec 31, 2022 | - | |
SC 13G | Feb 14, 2023 | - | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate PRVA share value held by 13F filers tracked by SignalX, by quarter.
- FMR LLC (Fidelity)+995.5K (+8%)
- Goldman Sachs Group+445.2K (+50%)
- Renaissance Technologies LLC+262.5K (+51%)
- State Street Corp+219.7K (+5%)
- Dimensional Fund Advisors+142.7K (+6%)
- Citadel Advisors LLC236.4K (-31%)
- Bank of America Corp157.6K (-11%)
- Morgan Stanley117.0K (-11%)
- BNY Mellon102.0K (-3%)
- Northern Trust94.1K (-7%)
- Franklin Resources+1.48M
- Coatue Management+27.2K
- Vanguard Group Inc−12.00M
- Invesco Ltd−427.6K
- JPMorgan Chase & Co−122.0K
- AlTi Global, Inc.−112.6K
- Two Sigma Investments−15.6K
Source: 13F-HR filings on SEC EDGAR (aggregated from 213 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest PRVA SEC filings in 2026?
Privia Health Group, Inc. (PRVA) has filed a 10-K annual report on February 27, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on August 6, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did PRVA file its most recent 10-K annual report?
Privia Health Group, Inc. (PRVA) filed its most recent 10-K annual report on February 27, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view PRVA 10-Q quarterly reports?
Privia Health Group, Inc. (PRVA)'s most recent 10-Q quarterly report was filed on May 7, 2026. SignalX displays every PRVA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has PRVA filed recently?
Privia Health Group, Inc. (PRVA)'s most recent 8-K was filed on August 6, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find PRVA insider trading activity (Form 4)?
SignalX aggregates every PRVA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does PRVA file with the SEC?
Privia Health Group, Inc. (PRVA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new PRVA filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Privia Health Group, Inc. (PRVA).
What is PRVA's SEC CIK number?
Privia Health Group, Inc. (PRVA)'s SEC CIK (Central Index Key) number is 1759655. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1759655 to look up all PRVA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find PRVA return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Privia Health Group, Inc. (PRVA) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Privia Health Group, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 35+ filings.